AMRS - Amyris, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.4900
-0.1700 (-4.64%)
As of 12:40PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close3.6600
Open3.6500
Bid3.49 x 900
Ask3.50 x 1200
Day's Range3.4700 - 3.7500
52 Week Range2.9200 - 9.2900
Volume369,482
Avg. Volume1,291,077
Market Cap267.076M
Beta (3Y Monthly)-0.08
PE Ratio (TTM)N/A
EPS (TTM)-3.03
Earnings DateMar 13, 2019 - Mar 18, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.50
Trade prices are not sourced from all markets
  • GlobeNewswire18 days ago

    Amyris Announces Signing of Nutritional Product Royalty Agreement

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has signed a long-term agreement with Xinfu of China for a significant initial payment and a long-term minimum annual share of an existing nutritional product royalty arrangement. This agreement enables Amyris to monetize a portion of the long-term royalty opportunity for this product upfront to better manage volatility in a high-margin revenue stream while maintaining access to future upside in the royalty payment structure. “We are very pleased with our relationship with Xinfu, which is an extension of existing strong relationships we have built within China over the last year,” said John Melo, Amyris President & CEO.

  • Hedge Funds Are Crazy About Amyris Inc (AMRS)
    Insider Monkey26 days ago

    Hedge Funds Are Crazy About Amyris Inc (AMRS)

    At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]

  • Phil Hempleman’s Ardsley Partners’ Returns, AUM and Holdings
    Insider Monkey29 days ago

    Phil Hempleman’s Ardsley Partners’ Returns, AUM and Holdings

    For more than thirty years, Philip Hempleman’s Ardsley Partners has been focusing on generating attractive returns to clients, by picking the best stocks and managing portfolios designed to seek out opportunity. This Stamford, Connecticut-based, long-short equity management firm, is launched back in March 1987 by Philip Hempelman, its current Managing Partner, Chief Investment Officer, and […]

  • GlobeNewswirelast month

    Amyris Receives GRAS Notification from FDA for its New, Sugarcane-Derived, Zero Calorie Sweetener

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announced today that it has received a successful GRAS notification from the US Food and Drug Administration (FDA) for its zero calorie sweetener. With this notification, the FDA has accepted the unanimous conclusion of a panel of food-safety experts, we announced on August 30, 2018, that Amyris’s zero calorie sweetener made from sugarcane is safe for use as a sweetener. The sweetener has the highest level of purity available today, the best taste of any alternative sweetener, and is made from a sustainable production process using fermentation.

  • GlobeNewswirelast month

    Amyris Closes on Debt Solution

    Amyris, Inc. (AMRS) (the “Company”), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has successfully closed on the previously-announced sale of $60 million of unsecured convertible senior notes (the "Notes"), in a private placement with two “accredited investors” (as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933). “We are very pleased with the support of our investors in addressing and simplifying our debt while we continue to deliver significant product sales growth across our business and pursue a truly exciting opportunity for us to disrupt the sweetener market with a healthier alternative,” said John Melo, Amyris President and CEO.

  • Health Care Digest: Where were the women in Gilead's CEO search — and more
    American City Business Journalslast month

    Health Care Digest: Where were the women in Gilead's CEO search — and more

    Gilead's CEO search, Amyris' cannabis consideration and Principia's opportunity in this week's Health Care Digest.

  • GlobeNewswirelast month

    Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand

    EMERYVILLE, Calif. and LEÓN, Spain, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (AMRS), a leader in the development and production of pure, sustainable, fermentation-derived ingredients for Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has executed an expanded agreement for its existing production contract with ADL Bionatur Solutions (MAB:ADL), through its fermentation division ADL Biopharma. ADL Bionatur, a European leader in research and development of health products, services and industrial fermentation production, provides cost effective, contract manufacturing capabilities.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of AMRS earnings conference call or presentation 13-Nov-18 9:30pm GMT

    Q3 2018 Amyris Inc Earnings Call

  • GlobeNewswirelast month

    Amyris Celebrates Launch of New Zero Calorie, Naturally-Derived Sweetener

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announced the accelerated commercialization of its new zero calorie, sugarcane-derived sweetener in 2019 in partnership with several food and beverage industry leaders. Amyris and its partners are ushering in the next wave in better-for-you, better-for-the planet sweeteners. While many other sweeteners on the market today are made with impurities that may result in a bitter aftertaste, Amyris’s sweetener is made from sugarcane using a proprietary process of fermentation to create the product at scale, yielding a sweetener with 95 percent purity – far higher than competitors.

  • Once a cleantech darling, this East Bay company looks to pour it on with syn-bio sweetener
    American City Business Journals2 months ago

    Once a cleantech darling, this East Bay company looks to pour it on with syn-bio sweetener

    The company pivoted from drugs to biofuels to health and beauty products. Now it rolling out its first entry in the $90 billion sugars and sweeteners market.

  • U.S. and China set to finalize a trade deal in the next three months
    Yahoo Finance2 months ago

    U.S. and China set to finalize a trade deal in the next three months

    Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:00 a.m. ET.

  • GlobeNewswire2 months ago

    Amyris Partners with Camil Alimentos to Deliver Zero Calorie Sweetener Made from Sugarcane to Brazilian Consumers

    Amyris, Inc. (AMRS), a leader in the research, development and production of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, has announced today a new partnership with Camil Alimentos (B3:CAML3), one of the largest food companies in Latin America to meet growing consumer demand for zero calorie natural sweeteners. The agreement, which provides exclusivity between Camil Alimentos and Amyris in Latin America, consists of the development of an innovative option of a natural sweetener, zero calorie and extracted from sugarcane. The partnership which will begin in Brazil, a country in which the company leads the sugar category and offers the most complete portfolio of the segment, will be the first market to receive the innovation.

  • GlobeNewswire2 months ago

    Amyris Partners with Givaudan to Introduce a Tabletop Application for its Zero Calorie, Naturally Sourced Sweetener

    Amyris, Inc. (AMRS), a leader in the research, development and production of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, recently announced the launch of a new, sugarcane-derived, zero calorie sweetener. Today, Amyris announces the introduction of a new tabletop sweetener application developed in collaboration with Givaudan, a flavor industry leader in the science behind sugar and taste. To address this, Amyris has developed a sweetener that is naturally sourced from sugarcane, has zero calories and has the best taste profile of any sweetener on the market.

  • Here's Why Amyris Can't Stop Sliding This Week
    Motley Fool2 months ago

    Here's Why Amyris Can't Stop Sliding This Week

    The company published SEC filings that go into more detail than its recent press release -- and investors don't like what they see.

  • Here's Why Amyris Is Getting Obliterated Today
    Motley Fool2 months ago

    Here's Why Amyris Is Getting Obliterated Today

    The synthetic biology pioneer reported third-quarter 2018 operating results.

  • GlobeNewswire2 months ago

    Amyris Reports Third Quarter 2018 Financial Results

    Q3 2018 GAAP revenue of $14.9 million, compared with GAAP revenue of $24.2 million for Q3 2017. Third-quarter revenue of $14.9 million compared with the same period in 2017 of.

  • Benzinga2 months ago

    Amyris Q3 Earnings Outlook

    Amyris, Inc. (NASDAQ: AMRS ) announces its next round of earnings this Tuesday, Nov. 13. Here's Benzinga's advanced look at Amyris' Q3 earnings report. Earnings and Revenue Based on Amyris management projections, ...

  • Simply Wall St.2 months ago

    Amyris Inc (NASDAQ:AMRS): Is Breakeven Near?

    Amyris Inc’s (NASDAQ:AMRS): Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The US$472m market-cap posted a loss in its most recent financial year of -US$93m and Read More...

  • GlobeNewswire2 months ago

    Amyris Further Expands Relationship with Yifan Pharmaceutical Co., Ltd.

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has already expanded its original collaboration with Yifan Pharmaceutical Co., Ltd. (SZ.002019) (“Yifan”) from its September 2018 agreement. Yifan will add a second molecule from Amyris to its vitamin portfolio. This new multi-million-dollar collaboration between Amyris and Yifan deepens the partnership between the two companies, with immediate revenue from developing products and expected product commercialization as early as 2021, as well as plans for additional products in the future.

  • Amyris (AMRS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Zacks2 months ago

    Amyris (AMRS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    Amyris (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire3 months ago

    Amyris to Announce Third Quarter 2018 Financial Results on Tuesday, November 13, 2018

    EMERYVILLE, Calif., Oct. 30, 2018 -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2018 after market close on Tuesday,.

  • GlobeNewswire3 months ago

    Amyris Partners with IPCA Labs to Earn the 2018 CPhI Award for Excellence in Pharma: API Development

    EMERYVILLE, Calif. and MADRID, Spain, Oct. 23, 2018 -- At the prestigious CPhI Pharma Awards Gala held October 9, in Madrid, Ipca Laboratories, Ltd. was awarded the 2018 CPhI.

  • Company behind Chanel perfume gets into sweetener business
    Yahoo Finance Video2 months ago

    Company behind Chanel perfume gets into sweetener business

    The Bay area company Amyris unveils a zero calorie naturally sourced sweetener in an attempt to carve out health issues for consumers. Yahoo Finance’s Alexis Christoforous speaks to Amyris CEO John Melo.